J. Taprogge

2.2k total citations
16 papers, 136 citations indexed

About

J. Taprogge is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J. Taprogge has authored 16 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Radiation and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J. Taprogge's work include Radiopharmaceutical Chemistry and Applications (9 papers), Radiation Dose and Imaging (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). J. Taprogge is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Radiation Dose and Imaging (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). J. Taprogge collaborates with scholars based in United Kingdom, Sweden and Netherlands. J. Taprogge's co-authors include Glenn Flux, Jonathan Gear, Johan Gustafsson, Iain Murray, Francesca Leek, Owen White, Sarah Chittenden, Elizabeth Miles, Christopher Parker and Jonathan Wadsley and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Physics in Medicine and Biology.

In The Last Decade

J. Taprogge

13 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Taprogge United Kingdom 8 102 47 39 25 13 16 136
Alex Vergara Gil France 8 153 1.5× 132 2.8× 53 1.4× 9 0.4× 12 0.9× 15 202
Wesley E. Bolch United States 5 289 2.8× 225 4.8× 113 2.9× 5 0.2× 17 1.3× 6 323
Avery Peterson United States 8 123 1.2× 46 1.0× 42 1.1× 1 0.0× 26 2.0× 10 144
Johannes Czernin United States 3 229 2.2× 13 0.3× 21 0.5× 6 0.2× 16 1.2× 3 296
Marjolaine Fourcade France 4 70 0.7× 38 0.8× 35 0.9× 12 0.9× 6 97
Julie Morvan France 5 58 0.6× 32 0.7× 33 0.8× 1 0.0× 3 0.2× 10 92
Beverley F. Holman United Kingdom 4 56 0.5× 17 0.4× 81 2.1× 9 0.7× 9 134
Julien Salvadori France 8 121 1.2× 47 1.0× 26 0.7× 26 2.0× 18 168
R. Cropp Canada 3 69 0.7× 26 0.6× 18 0.5× 3 0.1× 8 0.6× 3 102
Alexis Beaulieu Canada 4 102 1.0× 15 0.3× 44 1.1× 3 0.1× 84 6.5× 8 156

Countries citing papers authored by J. Taprogge

Since Specialization
Citations

This map shows the geographic impact of J. Taprogge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Taprogge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Taprogge more than expected).

Fields of papers citing papers by J. Taprogge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Taprogge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Taprogge. The network helps show where J. Taprogge may publish in the future.

Co-authorship network of co-authors of J. Taprogge

This figure shows the co-authorship network connecting the top 25 collaborators of J. Taprogge. A scholar is included among the top collaborators of J. Taprogge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Taprogge. J. Taprogge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gustafsson, Johan, Erik Larsson, Michael Ljungberg, et al.. (2025). A validation protocol for 177Lu-SPECT image quantification as a basis for multi-centre kidney dosimetry. Physics in Medicine and Biology. 70(11). 115001–115001.
2.
Taprogge, J., Iain Murray, Francesca Leek, et al.. (2025). Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer. European Thyroid Journal. 14(4).
3.
Taprogge, J., Jonathan Gear, Iain Murray, et al.. (2023). Initial results of the INSPIRE clinical trial—investigating radiation dosimetry for differentiated thyroid cancer patients. SHILAP Revista de lepidopterología. 3. 964478–964478. 2 indexed citations
4.
Taprogge, J., Alex Vergara Gil, Francesca Leek, et al.. (2023). Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3225–3234. 4 indexed citations
5.
Taprogge, J., Jonathan Gear, Rebecca Gregory, et al.. (2023). The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer. Journal of Nuclear Medicine. 64(7). 1125–1130. 6 indexed citations
6.
Gustafsson, Johan & J. Taprogge. (2023). Future trends for patient-specific dosimetry methodology in molecular radiotherapy. Physica Medica. 115. 103165–103165. 6 indexed citations
7.
Taprogge, J., et al.. (2023). Radiation protection aspects for alpha therapies. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 67(1). 4–13.
8.
Taprogge, J., et al.. (2022). Quantification and dosimetry of small volumes including associated uncertainty estimation. EJNMMI Physics. 9(1). 86–86. 6 indexed citations
10.
Gustafsson, Johan & J. Taprogge. (2021). Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy. Physics in Medicine and Biology. 67(2). 25003–25003. 17 indexed citations
11.
Taprogge, J., et al.. (2021). Adjustment of the iodine ICRP population pharmacokinetic model for the use in thyroid cancer patients after thyroidectomy. Journal of Radiological Protection. 41(4). 1034–1044. 10 indexed citations
12.
Flux, Glenn, et al.. (2021). Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy. Seminars in Nuclear Medicine. 52(2). 167–177. 7 indexed citations
13.
Taprogge, J., Jonathan Wadsley, Elizabeth Miles, & Glenn Flux. (2020). Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy. Clinical Oncology. 33(2). 131–136. 10 indexed citations
14.
Taprogge, J., Francesca Leek, & Glenn Flux. (2019). Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(3). 271–277. 11 indexed citations
15.
Taprogge, J., Iain Murray, Jonathan Gear, et al.. (2019). Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(4). 884–892. 20 indexed citations
16.
Gear, Jonathan, J. Taprogge, Owen White, & Glenn Flux. (2019). Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimation. EJNMMI Physics. 6(1). 1–1. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026